Gene Therapy for Neuroprotection and Neurorestoration (Part II)
Page: [163 - 163] Pages: 1
* (Excluding Mailing and Handling)
[1]
Rehman S, Nabi B, Pottoo FH, et al. Nanoparticle based gene therapy approach: A pioneering rebellion in the management of psychiatric disorders. Curr Gene Ther 2020; 20(3): 164-73. [http://dx.doi.org/10.2174/1566523220666200607185903] [PMID: 32515310]
Shah P, Chavda V, Patel S, et al. Promising anti-stroke signature of Voglibose: Investigation through in-silico molecular docking and virtual screening in in-vivo animal studies. Curr Gene Ther 2020; 20(3): 223-35. [http://dx.doi.org/10.2174/1566523220999200726225457]
[4]
Iqubal A, Iqubal MK, Khan A, et al. Gene therapy, a novel therapeutic tool, for neurological disorders: Current progress, challenges and future prospective. Curr Gene Ther 2020; 20(3): 184-94. [http://dx.doi.org/10.2174/1566523220999200716111502] [PMID: 32674730]
[5]
Behl T, Kaur I, Kumar A, et al. Gene therapy in the management of Parkinson’s disease: Potential of GDNF as a promising therapeutic strategy. Curr Gene Ther 2020; 20(3): 207-22. [http://dx.doi.org/10.2174/1566523220999200817164051] [PMID: 32811394]
[6]
Agarwal S, Agarwal V, Agarwal M, Singh M. Exosomes: Structure, biogenesis, types and application in diagnosis, and gene and drug delivery. Curr Gene Ther 2020; 20(3): 195-206. [http://dx.doi.org/10.2174/1566523220999200731011702] [PMID: 32787759]
Download PDF Flyer